Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

254.92

Today's Change

+6.27 (2.52%)

Day's Change

246.83 - 255.30

Trading Volume

91,928

Overview

Market Cap

26 Billion

Shares Outstanding

104 Million

Avg Volume

256,666

Avg Price (50 Days)

219.34

Avg Price (200 Days)

154.43

PE Ratio

318.96

EPS

0.80

Earnings Announcement

13-Feb-2025

Previous Close

248.65

Open

247.50

Day's Range

246.83 - 255.3

Year Range

85.6 - 271.37

Trading Volume

92,191

Price Change Highlight

1 Day Change

2.62%

5 Day Change

2.07%

1 Month Change

15.07%

3 Month Change

48.21%

6 Month Change

81.63%

Ytd Change

164.97%

1 Year Change

169.45%

3 Year Change

313.03%

5 Year Change

978.49%

10 Year Change

23097.27%

Max Change

22088.70%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment